Heat Biologics Inc - ESG Rating & Company Profile powered by AI
This assessment of Heat Biologics Inc employs information from across the internet and also from public disclosures by Heat Biologics Inc. This article contains a questions and answers table about Heat Biologics Inc. The page is a free Environmental, Social and Governance report covering Heat Biologics Inc.
Heat Biologics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 2.7, social score of 0.0 and governance score of 2.0.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | Heat Biologics Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Heat Biologics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Heat Biologics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Heat Biologics Inc report the average age of the workforce?
Sign up for free to unlockDoes Heat Biologics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Heat Biologics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Heat Biologics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Heat Biologics Inc offer flexible work?
Sign up for free to unlockDoes Heat Biologics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Heat Biologics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Heat Biologics Inc conduct supply chain audits?
Sign up for free to unlockDoes Heat Biologics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Heat Biologics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Heat Biologics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Heat Biologics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Heat Biologics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Heat Biologics Inc disclose water use targets?
Sign up for free to unlockDoes Heat Biologics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Heat Biologics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Heat Biologics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Heat Biologics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Heat Biologics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Heat Biologics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Heat Biologics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Heat Biologics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Heat Biologics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Heat Biologics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Heat Biologics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Heat Biologics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Heat Biologics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Heat Biologics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Heat Biologics Inc disclose its waste policy?
Sign up for free to unlockDoes Heat Biologics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Heat Biologics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Heat Biologics Inc disclose energy use targets?
Sign up for free to unlockDoes Heat Biologics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Heat Biologics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Heat Biologics Inc
These potential risks are based on the size, segment and geographies of the company.
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patient's immune system against cancer through T-cell activation and expansion. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer; and HS-130 that is in phase I clinical trial for the treatment of advanced solid tumors. Its preclinical stage products include PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25; TNFRSF25 modulators for various immunotherapy approaches; and COVID-19 vaccine. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.